ARTICLE | Clinical News
Aplenzin bupropion hydrobromide regulatory update
May 23, 2011 7:00 AM UTC
FDA updated the label of Alpenzin bupropion from Valeant to include a boxed warning about reports of serious neuropsychiatric events with use of bupropion for smoking cessation, including but not limi...